Takefumi Doi

7.7k total citations · 1 hit paper
153 papers, 4.6k citations indexed

About

Takefumi Doi is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Takefumi Doi has authored 153 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 23 papers in Surgery and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Takefumi Doi's work include Peroxisome Proliferator-Activated Receptors (19 papers), RNA and protein synthesis mechanisms (13 papers) and RNA modifications and cancer (13 papers). Takefumi Doi is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (19 papers), RNA and protein synthesis mechanisms (13 papers) and RNA modifications and cancer (13 papers). Takefumi Doi collaborates with scholars based in Japan, United States and Germany. Takefumi Doi's co-authors include Tatsuhiko Kodama, Satoshi Obika, Takeshi Imanishi, Daishu Nanbu, Takao Hamakubo, Keisuke Tachibana, Kenji Ishimoto, Daisuke Yamasaki, Takahiro Kodama and Yoshiyuki Hari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Takefumi Doi

146 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides

1998 579 citations Takefumi Doi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takefumi Doi Japan	35	3.0k	712	457	442	380	153	4.6k
Karol Bomsztyk United States	43	4.0k 1.3×	881 1.2×	746 1.6×	281 0.6×	522 1.4×	123	5.6k
Joan Gil Spain	38	2.9k 1.0×	557 0.8×	509 1.1×	254 0.6×	918 2.4×	110	4.9k
Makoto Takeuchi Japan	37	2.7k 0.9×	1.2k 1.7×	218 0.5×	321 0.7×	395 1.0×	189	4.6k
David K. Han United States	33	3.6k 1.2×	1.4k 2.0×	611 1.3×	306 0.7×	502 1.3×	61	5.6k
Frank Eßmann Germany	40	2.7k 0.9×	840 1.2×	685 1.5×	322 0.7×	1.1k 2.8×	79	4.5k
Silvia Bruno Italy	32	2.9k 1.0×	1.0k 1.4×	740 1.6×	349 0.8×	1.1k 2.8×	105	5.2k
Hee Gu Lee South Korea	37	2.0k 0.7×	854 1.2×	522 1.1×	259 0.6×	729 1.9×	140	3.8k
Sreenivasan Ponnambalam United Kingdom	42	2.6k 0.9×	1.0k 1.4×	365 0.8×	331 0.7×	425 1.1×	126	4.4k
Ali Bettaı̈eb France	39	2.2k 0.7×	727 1.0×	339 0.7×	231 0.5×	733 1.9×	132	4.0k
Lily Huang United States	27	2.2k 0.8×	439 0.6×	278 0.6×	196 0.4×	533 1.4×	62	3.7k

Countries citing papers authored by Takefumi Doi

Since Specialization

Citations

This map shows the geographic impact of Takefumi Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takefumi Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takefumi Doi more than expected).

Fields of papers citing papers by Takefumi Doi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takefumi Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takefumi Doi. The network helps show where Takefumi Doi may publish in the future.

Co-authorship network of co-authors of Takefumi Doi

This figure shows the co-authorship network connecting the top 25 collaborators of Takefumi Doi. A scholar is included among the top collaborators of Takefumi Doi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takefumi Doi. Takefumi Doi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watanabe, Takuya, Tadashi Sakane, Kosuke Fujino, et al.. (2025). Bronchopleural fistula: a multi-institutional analysis of the treatment outcomes and prognostic factors in the ESSG-01 study. European Journal of Cardio-Thoracic Surgery. 67(6). 1 indexed citations

Bando, Hironori, Maki Kanzawa, Takefumi Doi, et al.. (2025). Utility of gel filtration chromatography in evaluating successful resection of ectopic adrenocorticotropic hormone-producing tumor: a case report and literature review. Endocrine Journal. 72(10). 1127–1134.

Tanaka, Masato, Keisuke Shirakura, Takuya Yamamoto, et al.. (2024). Endothelial ROBO4 suppresses PTGS2/COX-2 expression and inflammatory diseases. Communications Biology. 7(1). 599–599. 8 indexed citations

Lenz, Heinz‐Josef, Guillem Argilés, Maja J.A. de Jonge, et al.. (2024). A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumors. ESMO Open. 9(11). 103729–103729. 5 indexed citations

Tanaka, Yugo, et al.. (2023). Programmed death ligand‐1 expression and occult lymph node metastasis in non‐small cell lung cancer. Thoracic Cancer. 14(18). 1774–1781. 2 indexed citations

Tanaka, Yugo, Takefumi Doi, Hironori Sakai, et al.. (2023). Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur–uracil as postoperative adjuvant chemotherapy. Surgery Today. 53(9). 1057–1063.

Shirakura, Keisuke, Masato Tanaka, Nobumasa Hino, et al.. (2021). HDAC inhibitor, MS-275, increases vascular permeability by suppressing Robo4 expression in endothelial cells. Tissue Barriers. 9(3). 1911195–1911195. 12 indexed citations

Zhang, Ji, Yoshihiro Matsumura, Takeshi Kawamura, et al.. (2021). Ubiquitination‐dependent and ‐independent repression of target genes by SETDB1 reveal a context‐dependent role for its methyltransferase activity during adipogenesis. Genes to Cells. 26(7). 513–529. 6 indexed citations

Nakamura, Miki, Nobumasa Hino, Jumpei Nogami, et al.. (2019). Cell-autonomous and redundant roles of Hey1 and HeyL in muscle stem cells: HeyL requires Hes1 to bind diverse DNA sites. Development. 146(4). 38 indexed citations

10.

Shirakura, Keisuke, Toru Tanaka, So‐ichiro Fukada, et al.. (2018). The Robo4-TRAF7 complex suppresses endothelial hyperpermeability in inflammation. Journal of Cell Science. 132(1). 22 indexed citations

11.

Matsumura, Yoshihiro, Ryo Nakaki, Takeshi Inagaki, et al.. (2015). H3K4/H3K9me3 Bivalent Chromatin Domains Targeted by Lineage-Specific DNA Methylation Pauses Adipocyte Differentiation. Molecular Cell. 60(4). 584–596. 162 indexed citations

12.

Okada, Yoshiaki, Miho Watanabe, Tomoko Nakai, et al.. (2012). Embryonic stem cell differentiation system for evaluating gene functions involved in physiological megakaryocytic differentiation. Biochemical and Biophysical Research Communications. 419(3). 477–481. 1 indexed citations

13.

Yamasaki, Daisuke, Hitomi Nakamura, Keisuke Tachibana, et al.. (2011). Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms. European Journal of Cell Biology. 90(8). 657–664. 75 indexed citations

14.

Ishimoto, Kenji, Hiroki Nakamura, Keisuke Tachibana, et al.. (2009). Sterol-mediated Regulation of Human Lipin 1 Gene Expression in Hepatoblastoma Cells. Journal of Biological Chemistry. 284(33). 22195–22205. 67 indexed citations

15.

Tachibana, Keisuke, Daisuke Yamasaki, Kenji Ishimoto, & Takefumi Doi. (2008). The Role of PPARs in Cancer. PPAR Research. 2008(1). 102737–102737. 190 indexed citations

16.

Shirai, Heigoro, Takeshi Murakami, Yoshihiko Yamada, et al.. (1999). Structure and function of type I and II macrophage scavenger receptors. Mechanisms of Ageing and Development. 111(2-3). 107–121. 16 indexed citations

17.

Yamamoto, Kyoko, Takefumi Doi, T. IMANISHI, et al.. (1997). The lysine cluster in the collagen‐like domain of the scavenger receptor provides for its ligand binding and ligand specificity. FEBS Letters. 414(2). 182–186. 28 indexed citations

18.

Yagi, Kiyohito, et al.. (1992). Nucleotide Sequences of Membrane-Bound Hydrogenase Gene in Alcaligenes hydrogenophilus.. Chemical and Pharmaceutical Bulletin. 40(12). 3292–3296. 4 indexed citations

19.

Ravid, Katya, Takefumi Doi, David Beeler, David J. Kuter, & Robert Rosenberg. (1991). Transcriptional Regulation of the Rat Platelet Factor 4 Gene: Interaction between an Enhancer/Silencer Domain and the GATA Site. Molecular and Cellular Biology. 11(12). 6116–6127. 112 indexed citations

20.

Naito, Munekazu, Takahiro Kodama, A. Matsumoto, Takefumi Doi, & Keiji Takahashi. (1991). Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors.. PubMed Central. 139(6). 1411–23. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact